CIK: 0001595851 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $306M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| IWM | ISHARES TR | 250,000 | $50.18M | 16.4% | $200.71 | — | — | Call | 464287655 |
| XBI | SPDR SER TR | 300,000 | $26.79M | 8.8% | $89.29 | — | — | Put | 78464A870 |
| XBI | SPDR SER TR | 250,000 | $22.32M | 7.3% | $89.29 | — | — | Call | 78464A870 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 250,000 | $15.1M | 4.9% | $60.39 * | $20.94 | +146.1% | Call | 61559X104 |
| AXSM | AXSOME THERAPEUTICS INC | 165,000 | $13.13M | 4.3% | $79.59 * | $46.29 | +44.4% | COM | 05464T104 |
| BHVN | BIOHAVEN LTD | 275,000 | $11.77M | 3.8% | $42.80 * | $31.10 | 0.0% | COM | G1110E107 |
| SRPT | SAREPTA THERAPEUTICS INC | 100,000 | $9.643M | 3.2% | $96.43 | $95.99 | -0.1% | COM | 803607100 |
| — | AMBRX BIOPHARMA INC | 475,000 | $6.764M | 2.2% | $14.24 | $14.24 | — | COM | 641871108 |
| ROIV | ROIVANT SCIENCES LTD | 600,000 | $6.738M | 2.2% | $11.23 * | $9.66 | +0.9% | SHS | G76279101 |
| CYTK | CYTOKINETICS INC | 80,000 | $6.679M | 2.2% | $83.49 * | $33.30 | +8.7% | Call | 23282W605 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 300,000 | $6.534M | 2.1% | $21.78 * | $19.74 | -20.0% | COM | 92790C104 |
| KRYS | KRYSTAL BIOTECH INC | 50,000 | $6.203M | 2.0% | $124.06 * | $117.03 | -5.2% | COM | 501147102 |
| GPCR | STRUCTURE THERAPEUTICS INC | 150,000 | $6.114M | 2.0% | $40.76 | $44.30 | — | SPONSORED ADS | 86366E106 |
| TARS | TARSUS PHARMACEUTICALS INC | 300,000 | $6.075M | 2.0% | $20.25 * | $20.09 | -16.9% | COM | 87650L103 |
| APLS | APELLIS PHARMACEUTICALS INC | 100,000 | $5.986M | 2.0% | $59.86 | — | — | Call | 03753U106 |
| ARGX | ARGENX SE | 15,000 | $5.706M | 1.9% | $380.43 | $398.96 | — | SPONSORED ADR | 04016X101 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 27,500 | $5.264M | 1.7% | $191.41 * | $170.34 | 0.0% | COM | 02043Q107 |
| BBIO | BRIDGEBIO PHARMA INC | 125,000 | $5.046M | 1.6% | $40.37 * | $23.88 | +25.7% | COM | 10806X102 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 80,000 | $4.831M | 1.6% | $60.39 * | $20.94 | +146.1% | CLASS A ORD | 61559X104 |
| — | AEROVATE THERAPEUTICS INC | 210,000 | $4.752M | 1.6% | $22.63 | $17.95 | — | COM | 008064107 |
| SLNO | SOLENO THERAPEUTICS INC | 112,385 | $4.523M | 1.5% | $40.25 * | $28.45 | 0.0% | COM | 834203309 |
| PCVX | VAXCYTE INC | 70,000 | $4.396M | 1.4% | $62.80 * | $31.83 | +63.2% | COM | 92243G108 |
| TGTX | TG THERAPEUTICS INC | 250,000 | $4.27M | 1.4% | $17.08 * | $14.97 | -22.4% | COM | 88322Q108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 165,000 | $3.813M | 1.2% | $23.11 * | $10.97 | +1.9% | COM NEW | 30233G209 |
| TSHA | TAYSHA GENE THERAPIES INC | 2,100,000 | $3.717M | 1.2% | $1.77 * | $1.91 | +4.1% | COM SHS | 877619106 |
| — | DECIPHERA PHARMACEUTICALS IN | 225,000 | $3.629M | 1.2% | $16.13 | $12.72 | — | COM | 24344T101 |
| SVRA | SAVARA INC | 750,000 | $3.525M | 1.2% | $4.70 * | $3.83 | 0.0% | COM | 805111101 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 385,241 | $3.517M | 1.1% | $9.13 * | $12.86 | -33.0% | COM | 71722W107 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 15,000 | $3.471M | 1.1% | $231.38 * | $197.50 | -11.4% | COM | 558868105 |
| CABA | CABALETTA BIO INC | 150,000 | $3.405M | 1.1% | $22.70 * | $16.81 | 0.0% | COM | 12674W109 |
| REPL | REPLIMUNE GROUP INC | 400,000 | $3.372M | 1.1% | $8.43 * | $11.59 | 0.0% | COM | 76029N106 |
| — | REVANCE THERAPEUTICS INC | 375,000 | $3.296M | 1.1% | $8.79 | $24.96 | — | COM | 761330109 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 200,000 | $2.944M | 1.0% | $14.72 * | $27.45 | -44.2% | Call | 03237H101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 125,000 | $2.866M | 0.9% | $22.93 * | $17.94 | -2.4% | COM | 74366E102 |
| — | ASTRIA THERAPEUTICS INC | 335,000 | $2.573M | 0.8% | $7.68 | $8.90 | — | COM | 04635X102 |
| ASND | ASCENDIS PHARMA A/S | 20,000 | $2.519M | 0.8% | $125.95 | $124.74 | — | SPONSORED ADR | 04351P101 |
| ARVN | ARVINAS INC | 59,250 | $2.439M | 0.8% | $41.16 * | $23.38 | 0.0% | COM | 04335A105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 65,000 | $2.313M | 0.8% | $35.58 * | $20.61 | +48.8% | COM | 22663K107 |
| PMVP | PMV PHARMACEUTICALS INC | 725,000 | $2.248M | 0.7% | $3.10 * | $6.13 | -56.8% | COM | 69353Y103 |
| NTRA | NATERA INC | 35,000 | $2.192M | 0.7% | $62.64 * | $49.96 | 0.0% | COM | 632307104 |
| RVMD | REVOLUTION MEDICINES INC | 75,000 | $2.151M | 0.7% | $28.68 | — | — | Put | 76155X100 |
| — | CYMABAY THERAPEUTICS INC | 90,000 | $2.126M | 0.7% | $23.62 | $23.62 | — | COM | 23257D103 |
| KALV | KALVISTA PHARMACEUTICALS INC | 130,036 | $1.593M | 0.5% | $12.25 * | $9.96 | -8.6% | COM | 483497103 |
| ACAD | ACADIA PHARMACEUTICALS INC | 50,000 | $1.565M | 0.5% | $31.31 * | $27.16 | -12.1% | COM | 004225108 |
| — | MARINUS PHARMACEUTICALS INC | 135,000 | $1.467M | 0.5% | $10.87 | $10.87 | — | COM NEW | 56854Q200 |
| — | INHIBRX INC | 35,000 | $1.33M | 0.4% | $38.00 | $25.96 | — | COM | 45720L107 |
| COGT | COGENT BIOSCIENCES INC | 195,000 | $1.147M | 0.4% | $5.88 * | $10.99 | -30.3% | COM | 19240Q201 |
| QURE | UNIQURE NV | 165,000 | $1.117M | 0.4% | $6.77 * | $20.98 | -68.5% | SHS | N90064101 |
| CYTK | CYTOKINETICS INC | 10,000 | $835K | 0.3% | $83.49 * | $33.30 | +8.7% | COM NEW | 23282W605 |
| — | PERSPECTIVE THERAPEUTICS INC | 1,600,000 | $643K | 0.2% | $0.40 | $0.40 | — | COM | 46489V104 |
| — | BLUEBIRD BIO INC | 465,000 | $642K | 0.2% | $1.38 | $1.38 | — | COM | 09609G100 |
| — | VERONA PHARMA PLC | 30,000 | $596K | 0.2% | $19.88 | $21.14 | — | SPONSORED ADS | 925050106 |